Magellan Life Sciences Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Magellan Life Sciences General Information
Description
Developer of plant-based proteins designed to provide protein sweeteners for the food and beverage industries. The company's sweeteners are made using a proprietary production platform and novel protein-based molecules for use across a wide spectrum that can be consumed without worrying about sugar content and sugar-associated diseases, enabling clients to give their customers a non-calorific protein sweetener.
Contact Information
Website
www.magellanlifesciences.comCorporate Office
- Cannon Place
- 78 Cannon Street
- London EC4N 6AF
- England, United Kingdom
Corporate Office
- Cannon Place
- 78 Cannon Street
- London EC4N 6AF
- England, United Kingdom
Magellan Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Apr-2026 | Completed | Generating Revenue | |||
| 5. Grant | 01-Mar-2022 | Completed | Generating Revenue | |||
| 4. Seed Round | 02-Jun-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 02-Nov-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 22-Dec-2017 | $250K | $250K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Magellan Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | 3,409 | $0.012978 | $171.31 | $171.31 | 1x | $171.31 | 19.62% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Magellan Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Magellan Life Sciences Patents
Magellan Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3407733-A1 | Process for extracellular secretion of brazzein | Active | 27-Jan-2016 | ||
| EP-3407733-A4 | Process for extracellular secretion of brazzein | Active | 27-Jan-2016 | ||
| EP-3407733-B1 | Process for extracellular secretion of brazzein | Active | 27-Jan-2016 | ||
| ES-2904642-T3 | Process for extracellular secretion of brazzein | Active | 27-Jan-2016 | ||
| US-11613757-B2 | Process for extracellular secretion of brazzein | Active | 27-Jan-2016 | C12N15/70 |
Magellan Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Magellan Life Sciences Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovate UK | Government | |||
| Roquette Ventures | Corporate Venture Capital | Minority | ||
| SOSV | Venture Capital | Minority |
Magellan Life Sciences FAQs
-
When was Magellan Life Sciences founded?
Magellan Life Sciences was founded in 2013.
-
Where is Magellan Life Sciences headquartered?
Magellan Life Sciences is headquartered in London, United Kingdom.
-
What is the size of Magellan Life Sciences?
Magellan Life Sciences has 3 total employees.
-
What industry is Magellan Life Sciences in?
Magellan Life Sciences’s primary industry is Other Consumer Non-Durables.
-
Is Magellan Life Sciences a private or public company?
Magellan Life Sciences is a Private company.
-
What is Magellan Life Sciences’s current revenue?
The current revenue for Magellan Life Sciences is .
-
How much funding has Magellan Life Sciences raised over time?
Magellan Life Sciences has raised $1.18M.
-
Who are Magellan Life Sciences’s investors?
Innovate UK, Roquette Ventures, and SOSV have invested in Magellan Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
